Hinge Health, Inc. (HNGE) earnings date
Feb 9, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 35% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 35 days, typically, give or take 3 (last 6 releases) |
Last 6 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Mon, Nov 2, 2026 | after close | 33 | 8-K |
| Q2 FY2026 | Tue, Aug 4, 2026 | after close | 35 | 8-K |
| Q1 FY2026 | Tue, May 5, 2026 | after close | 35 | 8-K |
| Q4 FY2025 | Tue, Feb 10, 2026 | after close | 41 | 8-K |
| Q3 FY2025 | Tue, Nov 4, 2025 | after close | 35 | 8-K |
| Q2 FY2025 | Tue, Aug 5, 2025 | after close | 36 | 8-K |
What they guided beta
| Q3 FY2026 | "2026 revenue guidance midpoint raised to $880 million, reflecting 50% year-over-year growth" exhibit |
| Q3 FY2026 | "2026 non-GAAP operating margin midpoint raised to 30%, reflecting ~1,000 bps improvement year-over-year San Francisco, California – November 2, 2026 – Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2026 and provided a business update." exhibit |
| Q3 FY2026 | "Outlook: We are providing the following guidance for our fourth quarter 2026 and full year 2026:" exhibit |
| Q3 FY2026 | "Q4 2026: We expect revenue to be between $249 million and $251 million, reflecting year-over-year growth of 46% at the midpoint." exhibit |
| Q3 FY2026 | "We expect non-GAAP income from operations to be between $81 million and $83 million, reflecting year-over-year growth of 71% and non-GAAP operating margin of 33% at the midpoint, a ~470 bps increase over Q4 2025." exhibit |
| Q2 FY2026 | "2026 revenue guidance midpoint raised to $858 million, reflecting 46% year-over-year growth" exhibit |
| Q2 FY2026 | "The acquisition will combine Cylinder Health’s clinical expertise and existing market footprint with Hinge Health’s AI-powered care model and technology platform to deliver support in a single app with an integrated Gastrointestinal Care Program, expected to launch in 2027." exhibit |
| Q2 FY2026 | "The transaction is subject to customary closing conditions and is expected to close in the third quarter of 2026." exhibit |
| Q2 FY2026 | "Outlook: We are providing the following guidance for our third quarter 2026 and full year 2026:" exhibit |
| Q2 FY2026 | "Q3 2026: We expect revenue to be between $223 million and $225 million, reflecting year-over-year growth of 45% at the midpoint." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/HNGE
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/HNGE
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/HNGE/"><img src="https://veritasdata.dev/embed/HNGE.svg" alt="HNGE earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/HNGE/)
Script
<script async src="https://veritasdata.dev/embed/HNGE.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/HNGE"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.